logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

BRCA+ eBCa: prophylactic radiation cuts CBC risk in Israeli trial

Phase 2 trial shows 80% reduced risk for contralateral malignancy and delayed onset.